Literature DB >> 344208

Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge.

C C Shepard, L L Walker, R M Van Landingham.   

Abstract

Viable suspensions of BCG, an attenuated strain of Mycobacterium bovis, have been previously shown to immunize mice against infections with M. leprae. Usually, the mice have been vaccinated about 1 month before challenge. Experiments have now been carried out with single intradermal injections of BCG given before or after the M. leprae challenge. Approximately equal immunizing effect was seen in one experiment when the BCG was given at -168, -119, -70, and -28 days relative to challenge. Approximately equal protection was observed in another experiment when the vaccine was given at -28, +28, and +56 days. In the latter experiment, however, vaccine given at +91 days appeared to be somewhat less effective. Enlargement of the lymph nodes regional to the intradermal vaccine site persisted for at least the duration of the experiment, approximately 400 days. Thus, antigenic stimulation appears to have continued throughout the period of observation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344208      PMCID: PMC414095          DOI: 10.1128/iai.19.2.391-394.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE.

Authors:  C C SHEPARD
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

2.  Lymphocyte migration into cell-mediated immune lesions is inhibited by trypsin.

Authors:  G H Ranne; M E Smith; W L Ford
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

3.  Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

Authors:  P Minden; J K McClatchy; M Wainberg; D W Weiss
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.

Authors:  C Bucana; M G Hanna
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

5.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

6.  Trial of BCG vaccination against leprosy in Uganda.

Authors:  J A Brown; M M Stone; I Sutherland
Journal:  Lepr Rev       Date:  1969-01       Impact factor: 0.537

7.  Vaccination against human leprosy bacillus infections of mice: protection by BCG given during the incubation period.

Authors:  C C Shepard
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

8.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  BCG vaccination of children against leprosy. Preliminary findings of the WHO-controlled trial in Burma.

Authors:  L M Bechelli; G Garbajosa; K Uemura; V Engler; V Martínez Domínguez; L Paredes; T Sundaresan; G Koch; M Matejka
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

10.  Multiple skin testing in leprosy.

Authors:  R C Paul; J L Stanford; J W Carswell
Journal:  J Hyg (Lond)       Date:  1975-08
  10 in total
  8 in total

1.  Adoptively transferred reactivity to M. leprae in nude mice infected with M. leprae.

Authors:  E J Shannon; S Chehl; C K Job; R C Hastings
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

Review 2.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

3.  Effect of vaccination with refined components of the organism on infection of mice with Mycobacterium leprae.

Authors:  Maeya Ngamying; Pathom Sawanpanyalert; Raywadee Butraporn; Junjira Nikasri; Sang-Nae Cho; Louis Levy; Patrick J Brennan
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

5.  Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae.

Authors:  K Widebäck; G Kronvall; B Bjorvatn; O Closs; M Harboe
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.

Authors:  Thomas P Gillis; Michael V Tullius; Marcus A Horwitz
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

7.  Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.

Authors:  C C Shepard; R M van Landingham; L L Walker; S Z Ye
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.

Authors:  M J Lefford; R Morgan; P S Logie
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.